Mesirow Financial Investment Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Mesirow Financial Investment Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.42M	Buy	8,967 +4,426	+97%	+$598K	0.02%	242
2026 Q1	$580K	Buy	4,541 +367	+9%	+$45.8K	0.01%	338
2025 Q4	$509K	Sell	4,174 -993	-19%	-$114K	0.01%	327
2025 Q3	$518K	Buy	5,167 +626	+14%	+$56.4K	0.01%	371
2025 Q2	$377K	Sell	4,541 -4,071	-47%	-$325K	0.01%	403
2025 Q1	$698K	Sell	8,612 -1,469	-15%	-$131K	0.01%	305
2024 Q4	$908K	Hold	10,081	–	–	0.02%	277
2024 Q3	$996K	Hold	10,081	–	–	0.02%	271
2024 Q2	$935K	Hold	10,081	–	–	0.02%	258
2024 Q1	$957K	Buy	10,081 +300	+3%	+$27.8K	0.02%	256
2023 Q4	$873K	Buy	+9,781	New	+$726K	0.03%	239

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Mesirow Financial Investment Management's XBI Position: Q2 2026 in Review

Mesirow Financial Investment Management increased its State Street SPDR S&P Biotech ETF (XBI) stake by 97% in Q2 2026, buying an estimated $598K and bringing the position to 8,967 shares worth $1.42M. The position accounts for 0.02% of the portfolio, ranked #242.

Mesirow Financial Investment Management first reported a position in XBI in Q4 2023 and has held it in 11 quarters since. 932 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Mesirow Financial Investment Management held 8,967 shares of State Street SPDR S&P Biotech ETF worth $1.42M as of Q2 2026.
Mesirow Financial Investment Management bought 4,426 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $598K.
State Street SPDR S&P Biotech ETF made up 0.02% of Mesirow Financial Investment Management's portfolio in Q2 2026, its #242 holding.
Mesirow Financial Investment Management first reported a position in State Street SPDR S&P Biotech ETF in Q4 2023 and has held it in 11 quarters since.
932 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Mesirow Financial Investment Management's 13F filing for Q2 2026, filed 22 Jul 2026.